Brief Tobacco Cessation Counselling: Mini Train-the-trainers Program

NCT ID: NCT02508597

Last Updated: 2017-11-06

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

120 participants

Study Classification

INTERVENTIONAL

Study Start Date

2014-08-31

Study Completion Date

2017-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Physicians play a critical role in reducing tobacco use by advising smoking patients to quit. After receiving such advice to quit smoking, patients were more likely to report trying to quit, quitting for at least 24 hours, making more quit attempts, and having more successful quitting outcomes compared with those who received no such advice. On the other hand, most physicians are not performing smoking cessation counselling, and miss the opportunities to advise patients to quit smoking. One of the common reasons is the lack of time. Physicians are busy and cannot afford even one minute to advice their patients to quit smoking. Other barriers include lack of training and experience, lack of knowledge and skills, no awareness about the benefits and effects of physicians' advice, no incentives and no support or requirement from hospital management that they have to do it.

We designed a brief smoking cessation counselling model (AWARD) which takes only 10-20 seconds. We will train the physicians to perform the AWARD cessation counselling model in clinic, and encourage them to participate in our brief smoking cessation intervention project using the randomized controlled trail (RCT) design and to train more peer physicians to perform brief smoking cessation counseling. We propose to investigate the effect of the training program on physicians' knowledge of tobacco cessation, practice of performing cessation counselling, and attitudes toward tobacco control policies.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Participating hospitals/clinics will invite 100-120 internal medicine physicians to take part in the brief smoking counselling intervention project and participate in a half-day mini TTT training program. The training will cover the following topics:

* Goal and the details of the brief smoking counselling intervention;
* Objective of the mini TTT training program;
* Tobacco epidemic and control measures in China and the world;
* Physicians' role in tobacco control;
* Health risks of smoking, secondhand smoke exposure;
* WHO FCTC (Framework Convention on Tobacco Control) and the MPOWER measures;
* Brief smoking cessation counselling (AWARD model), and counselling skill with practice;
* Placebo counselling and counselling skill with practice.

On the training day, the investigators will explain at the beginning of the workshop the purpose of the training, and the details of the brief smoking cessation intervention to all physicians who attend the training workshop. The investigators will explain that the participation is totally voluntary, and the participants will be invited to complete a paper-and-pencil survey before and right after the training workshop, perform smoking cessation counselling or placebo counselling among patients at their clinics, and complete online survey at 6- and 12-month follow-up. Agreement to participate in the training program will be considered as consent and participants are required to sign a written consent form.

At the end of the workshop, participants should be confident to perform brief smoking cessation counselling and placebo counselling for patients.

We hypothesize that the training program will increase the participants' knowledge level of smoking and secondhand smoke exposure and the important role of physicians in tobacco control, increase their skill and confidence of performing smoking cessation counselling, and generate stronger support for tobacco control policies.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Smoking

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Smoking cessation intervention

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

HEALTH_SERVICES_RESEARCH

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Physicians receiving smoking cessation training

On the training day, the investigators will explain at the beginning of the workshop the purpose of the training, and the details of the brief smoking cessation intervention to all physicians who attend the training workshop.

Group Type OTHER

Physicians receiving smoking cessation training

Intervention Type OTHER

On the training day, the investigators will explain at the beginning of the workshop the purpose of the training, and the details of the brief smoking cessation intervention to all physicians who attend the training workshop.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Physicians receiving smoking cessation training

On the training day, the investigators will explain at the beginning of the workshop the purpose of the training, and the details of the brief smoking cessation intervention to all physicians who attend the training workshop.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Internal medicine physicians from participating hospitals/clinics.

Exclusion Criteria

* N/A
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

The University of Hong Kong

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Professor Lam Tai-Hing

Chair Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Tai Hing Lam, MD

Role: PRINCIPAL_INVESTIGATOR

The University of Hong Kong

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

5/F William MW Mong Block, LKS Faculty of Medicine Building, 21 Sassoon Road, Pokfulam

Hong Kong, Guangdong, China

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

China

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Tai Hing Lam, MD

Role: CONTACT

Phone: +852 3917 9287

Email: [email protected]

Christina Lam

Role: CONTACT

Phone: +852 3917 6662

Email: [email protected]

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

MiniTTT

Identifier Type: -

Identifier Source: org_study_id